Search by Drug Name or NDC
NDC 00310-0900-30 DUAKLIR PRESSAIR 400; 12 ug/1; ug/1 Details
DUAKLIR PRESSAIR 400; 12 ug/1; ug/1
DUAKLIR PRESSAIR is a RESPIRATORY (INHALATION) POWDER, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE.
MedlinePlus Drug Summary
Aclidinium is used as a long term treatment to prevent wheezing, shortness of breath, coughing, and chest tightness in patients with chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to air sacs in the lungs). Aclidinium is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
Related Packages: 00310-0900-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Aclidinium Oral Inhalation
Formoterol oral inhalation is used to control wheezing, shortness of breath, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of lung diseases that includes chronic bronchitis and emphysema). Formoterol is in a class of medications called long-acting beta agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
Related Packages: 00310-0900-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Formoterol Oral Inhalation
Product Information
| NDC | 00310-0900 |
|---|---|
| Product ID | 0310-0900_542906e1-4eb9-4718-a490-a3eb90975819 |
| Associated GPIs | |
| GCN Sequence Number | 073344 |
| GCN Sequence Number Description | aclidinium brom/formoterol fum AER POW BA 400-12 MCG INHALATION |
| HIC3 | B62 |
| HIC3 Description | BETA-ADRENERGIC AND ANTICHOLINERGIC COMBO, INHALED |
| GCN | 37735 |
| HICL Sequence Number | 041692 |
| HICL Sequence Number Description | ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE |
| Brand/Generic | Brand |
| Proprietary Name | DUAKLIR PRESSAIR |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | aclidinium bromide and formoterol fumarate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, METERED |
| Route | RESPIRATORY (INHALATION) |
| Active Ingredient Strength | 400; 12 |
| Active Ingredient Units | ug/1; ug/1 |
| Substance Name | ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Pharmaceutical Class | Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], beta2-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA210595 |
| Listing Certified Through | n/a |
Package
NDC 00310-0900-30 (00310090030)
| NDC Package Code | 0310-0900-30 |
|---|---|
| Billing NDC | 00310090030 |
| Package | 1 POUCH in 1 CARTON (0310-0900-30) / 1 INHALER in 1 POUCH / 30 POWDER, METERED in 1 INHALER |
| Marketing Start Date | 2022-08-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |